Lupus & antiphospholipid syndrome

Prediction model for renal outcomes in Latin American Mestizo patients with pure proliferative lupus nephritis

Lupus Sci MedPublished Retrospective cohort study

Authors' conclusion

Based on two readily available features at the time of diagnosis, the proposed model effectively stratifies Latin American mestizo patients with pure proliferative LN (ISN/RPS class III or IV) into three risk categories for poor renal outcome.

Study context

Population
Adult mestizo patients with incident, biopsy-proven pure proliferative lupus nephritis (LN) (ISN/RPS class III or IV), nine Chilean hospitals; external validation in Mexican patients93 Mexican validation patients
Participants
290 patients
Exposure
Risk categories by baseline eGFR <30 mL/min/m² and chronicity index >2
Outcome
Composite of:
  • Stage IV/V CKD
  • Dialysis
  • Death
Methodological detailsprognostic model development and validation, multicentre, multivariable Cox regression, internal validation by bootstrapping, external validation
  • Prognostic model development and validation
  • Multicentre
  • Multivariable Cox regression
  • Internal validation by bootstrapping
  • External validation

Main finding

As reported in the abstract

Poor renal outcome, independent baseline factors
Hazard ratio (95% CI)P value
eGFR <30 mL/min/m²
3.82(2.15–6.78)
P < 0.001
Chronicity index >2
2.01(1.18–3.43)
P = 0.01

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
Primary outcome by risk categoryHigh riskvs Intermediate risk3.22 (1.64–6.34)P = 0.001
Primary outcome by risk categoryIntermediate riskvs Low risk2.41 (1.35–4.30)P = 0.003

Three-tier model in external validation cohort, concordance index

Concordance index
79% (95% CI 71% to 87%; p<0.001)

Original publication

Prediction model for renal outcomes in Latin American Mestizo patients with pure proliferative lupus nephritis. Lupus Sci Med. Published 6 October 2025. doi:10.1136/lupus-2025-001649

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.